Share
1,195 Posts.
lightbulb Created with Sketch. 937
clock Created with Sketch. 11/02/21
12:23
Share
Originally posted by needle:
↑
Book value at the time R&P......this is what they actually achieved.It is exactly the same technology that makes up our Cantrixil. So are the management of KZA going to disclose, in accordance with their ASX obligations. (At least when the NOX poster is made availalbe). 20/1 they will. Please surprise me CEO and we greeted with complimentary praise. 90% of investors in KZA (or potential investors would not have any idea of what is happening with NOX and the association of our drug Cantrixil) Yon need to tell the market/disclose in accordance with Company obligations. I am sick of it....and my name features in a number of files at ASIC. It is the perfect right for investors to present their concerns, with regard to disclosure. And again correspondence may be forwarded to ASIC on this matter. until post April. Look anything can happen in April at AACR, when these likely 3 sets of positive data released.
Expand
Hi needle, I am waiting for the Kazia Chairman's report, which is due approximately 19 February or 22 February.
